These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17563308)

  • 1. Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease.
    Mudaliar S; Henry RR
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S83-92. PubMed ID: 17563308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.
    Rave K; de la Peña A; Tibaldi FS; Zhang L; Silverman B; Hausmann M; Heinemann L; Muchmore DB
    Diabetes Care; 2007 Jul; 30(7):1777-82. PubMed ID: 17456839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD.
    Kempsford R; Norris V; Siederer S
    Pulm Pharmacol Ther; 2013 Apr; 26(2):256-64. PubMed ID: 23232038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.
    Alcázar Navarrete B; Casanova C; Miravitlles M; de Lucas P; Riesco JA; Rodríguez González-Moro JM;
    Arch Bronconeumol; 2015 Apr; 51(4):193-8. PubMed ID: 25540900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.
    Petersen AH; Korsatko S; Köhler G; Wutte A; Olschewski H; Sparre T; Råstam J; Wollmer P; Pieber TR
    Br J Clin Pharmacol; 2010 Mar; 69(3):271-8. PubMed ID: 20233198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin.
    Arnolds S; Heise T
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):555-71. PubMed ID: 18054735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled insulin for diabetes mellitus.
    Guevara CA
    N Engl J Med; 2007 May; 356(20):2106-7; author reply 2108. PubMed ID: 17514779
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M; Esquinas C; Miravitlles M
    Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids for chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Novelli L; Matera MG
    Expert Opin Pharmacother; 2013 Dec; 14(18):2489-99. PubMed ID: 24138334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
    Pauwels RA
    Proc Am Thorac Soc; 2004; 1(2):73-6. PubMed ID: 16113416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
    Donohue JF; Ohar JA
    Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?
    Castiglia D; Battaglia S; Benfante A; Sorino C; Scichilone N
    Drugs Aging; 2016 Jun; 33(6):375-85. PubMed ID: 27138954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment implications on morbidity and mortality in COPD.
    Mapel DW
    Chest; 2004 Aug; 126(2 Suppl):150S-158S; discussion 159S-161S. PubMed ID: 15302775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.